259 related articles for article (PubMed ID: 33146798)
21. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
22. [Differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma based on multi-modality texture features in
Zhang Y; Cheng C; Liu Z; Pan G; Sun G; Yang X; Zuo C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Oct; 36(5):755-762. PubMed ID: 31631623
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced ultrasound and contrast-enhanced computed tomography for differentiating mass-forming pancreatitis from pancreatic ductal adenocarcinoma: a meta-analysis.
Yang J; Huang J; Zhang Y; Zeng K; Liao M; Jiang Z; Bao W; Lu Q
Chin Med J (Engl); 2023 Sep; 136(17):2028-2036. PubMed ID: 36728948
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge.
Xiang P; Zhang X; Wang C; Lang Y; Xu L; Huang L; Shen J; Feng ST
BMC Cancer; 2019 Aug; 19(1):814. PubMed ID: 31419961
[TBL] [Abstract][Full Text] [Related]
25. Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
Marya NB; Powers PD; Chari ST; Gleeson FC; Leggett CL; Abu Dayyeh BK; Chandrasekhara V; Iyer PG; Majumder S; Pearson RK; Petersen BT; Rajan E; Sawas T; Storm AC; Vege SS; Chen S; Long Z; Hough DM; Mara K; Levy MJ
Gut; 2021 Jul; 70(7):1335-1344. PubMed ID: 33028668
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lopes Vendrami C; Shin JS; Hammond NA; Kothari K; Mittal PK; Miller FH
Abdom Radiol (NY); 2020 May; 45(5):1371-1386. PubMed ID: 31493022
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of MRI for the diagnosis of liver metastasis in patients with pancreatic adenocarcinoma.
Hong SB; Choi SH; Kim KW; Kim SY; Kim JH; Kim S; Lee NK
J Magn Reson Imaging; 2020 Jun; 51(6):1737-1744. PubMed ID: 31664776
[TBL] [Abstract][Full Text] [Related]
28. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
29. Concomitant Pancreatic Ductal Adenocarcinoma and Type 1 Autoimmune Pancreatitis: A Potential Issue in the Diagnosis of Carcinoma by Endoscopic Ultrasound-guided Fine-needle Biopsy.
Kachi K; Naitoh I; Ban T; Hayashi K; Yoshida M; Hori Y; Natsume M; Kato A; Kito Y; Saito K; Matsuo Y; Kato H; Naiki-Ito A; Takahashi S; Notohara K; Kataoka H
Intern Med; 2023 Feb; 62(4):545-551. PubMed ID: 35831103
[TBL] [Abstract][Full Text] [Related]
30. The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing.
Zhou W; Zhang D; Li Z; Jiang H; Li J; Ren R; Gao X; Li J; Wang X; Wang W; Yang Y
J Transl Med; 2021 May; 19(1):215. PubMed ID: 34006295
[TBL] [Abstract][Full Text] [Related]
31. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis.
Ichikawa S; Kromrey ML; Motosugi U; Onishi H
Abdom Radiol (NY); 2021 Feb; 46(2):636-646. PubMed ID: 32740865
[TBL] [Abstract][Full Text] [Related]
32. [Autoimmune pancreatitis versus pancreatic cancer].
Wessling J; Juchems M; Grenacher L; Schreyer AG
Radiologie (Heidelb); 2023 Dec; 63(12):886-893. PubMed ID: 37947862
[TBL] [Abstract][Full Text] [Related]
33. [Autoimmune pancreatitis: An update].
Helmberger T
Radiologe; 2016 Apr; 56(4):363-70. PubMed ID: 27025383
[TBL] [Abstract][Full Text] [Related]
34. Multiparameter diagnostic model based on
Wang G; Du L; Lu X; Chen S; Bi X; Zhang M; Luan X; Xu X; Zhang Z; Xu B; Yang J
Quant Imaging Med Surg; 2023 Sep; 13(9):5653-5663. PubMed ID: 37711769
[TBL] [Abstract][Full Text] [Related]
35. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
[TBL] [Abstract][Full Text] [Related]
36. Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma.
Ren H; Mori N; Hamada S; Takasawa C; Mugikura S; Masamune A; Takase K
Abdom Radiol (NY); 2021 Apr; 46(4):1640-1647. PubMed ID: 33037891
[TBL] [Abstract][Full Text] [Related]
37. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
[TBL] [Abstract][Full Text] [Related]
38. CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis.
Park S; Jang JK; Byun JH; Kim JH; Lee SS; Kim HJ; Hong SB; Park SH
Eur Radiol; 2021 May; 31(5):3383-3393. PubMed ID: 33123793
[TBL] [Abstract][Full Text] [Related]
39. A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on
Wei W; Jia G; Wu Z; Wang T; Wang H; Wei K; Cheng C; Liu Z; Zuo C
Jpn J Radiol; 2023 Apr; 41(4):417-427. PubMed ID: 36409398
[TBL] [Abstract][Full Text] [Related]
40. Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies.
Kim B; Lee SS; Sung YS; Cheong H; Byun JH; Kim HJ; Kim JH
J Magn Reson Imaging; 2017 Jan; 45(1):260-269. PubMed ID: 27273754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
